Sean Plummer
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Massachusetts General Hospital (2017–2025); Texas A&M University (2020–2026)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sean Plummer's research focuses on hematologic malignancies, particularly mantle cell lymphoma and diffuse large-B-cell lymphoma. He has investigated the efficacy of novel therapeutic combinations, including zanubrutinib, obinutuzumab, and venetoclax, for the first-line treatment of mantle cell lymphoma, with a specific emphasis on patients with TP53 mutations. His work also includes evaluating anti-CD19 CAR T-cell therapy for central nervous system diffuse large-B-cell lymphoma. Plummer has also contributed to the theoretical aspects of statistical modeling, with publications on evidence bounds in singular models and statistical guarantees for transformation-based models. His scholarly metrics include an h-index of 3, with 5 total publications and 276 citations.
Metrics
- h-index: 3
- Publications: 5
- Citations: 276
Selected Publications
-
Evidence Bounds in Singular Models: Probabilistic and Variational Perspectives (2026)
Collaboration Network
Top Collaborators
- Evidence Bounds in Singular Models: Probabilistic and Variational Perspectives
- Evidence Bounds in Singular Models: Probabilistic and Variational Perspectives
Similar Researchers
Based on overlapping research topics